Hubei Biocause Pharmaceutical000627 
$0.684.40%24h
4.40%24h
Global rank3539
Market cap$3.37B
Change 7d7.56%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield5.5%
Market capitalization of Hubei Biocause Pharmaceutical (000627)
As of January 2025, Hubei Biocause Pharmaceutical has a market cap of $3.37B. This makes Hubei Biocause Pharmaceutical the world's 3539th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Hubei Biocause Pharmaceutical from 1996 to 2024
-
Value:-
Market cap history of Hubei Biocause Pharmaceutical from 1996 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.78B | -7.39% |
| 2023 | $1.92B | -10.13% |
| 2022 | $2.14B | -4.53% |
| 2021 | $2.24B | -32.03% |
| 2020 | $3.30B | -30.82% |
| 2019 | $4.77B | 25.49% |
| 2018 | $3.80B | -29.87% |
| 2017 | $5.42B | 4.58% |
| 2016 | $5.18B | -28.90% |
| 2015 | $7.29B | 162.44% |
| 2014 | $2.78B | 56.49% |
| 2013 | $1.77B | -6.76% |
| 2012 | $1.90B | -1.40% |
| 2011 | $1.93B | -43.11% |
| 2010 | $3.39B | 24.24% |
| 2009 | $2.73B | 129.54% |
| 2008 | $1.19B | -70.98% |
| 2007 | $4.10B | 279.66% |
| 2006 | $1.08B | 56.91% |
| 2005 | $688.15M | -15.01% |
| 2004 | $809.72M | -12.84% |
| 2003 | $928.96M | -67.12% |
| 2002 | $2.83B | -15.39% |
| 2001 | $3.34B | 16.09% |
| 2000 | $2.88B | 92.20% |
| 1999 | $1.50B | 145.09% |
| 1998 | $610.75M | -25.83% |
| 1997 | $823.47M | -5.71% |
| 1996 | $873.38M | - |
000627 Market Cap Today is $3.37B 4.40% - 26 Jan 2025
View largest stocks by market cap 
